BrainStorm Cell Therapeutics

FDA sets advisory meeting date for Brainstorm’s ALS cell therapy
FDA sets advisory meeting date for Brainstorm’s ALS cell therapy
BioPharma Dive
BrainStorm Cell Therapeutics
FDA
NurOwn
cell therapy
ALS
Flag link:
BrainStorm Secures FDA Adcomm for ALS Therapy NurOwn
BrainStorm Secures FDA Adcomm for ALS Therapy NurOwn
BioSpace
BrainStorm Cell Therapeutics
NurOwn
ALS
FDA
Flag link:
BrainStorm Vows to Push for Adcomm Meeting on NurOwn in ALS
BrainStorm Vows to Push for Adcomm Meeting on NurOwn in ALS
BioSpace
BrainStorm Cell Therapeutics
NurOwn
ALS
FDA
Flag link:
Not once, but twice: BrainStorm shares tumble as FDA again knocks back ALS drug
Not once, but twice: BrainStorm shares tumble as FDA again knocks back ALS drug
Fierce Biotech
BrainStorm Cell Therapeutics
ALS
FDA
NurOwn
Flag link:
BrainStorm Brings MS Data on Heels of ALS BLA Announcement
BrainStorm Brings MS Data on Heels of ALS BLA Announcement
BioSpace
BrainStorm Cell Therapeutics
NurOwn
multiple sclerosis
MS
Flag link:
Highlighted by Amylyx, the ALS Space is Gaining Momentum
Highlighted by Amylyx, the ALS Space is Gaining Momentum
BioSpace
ALS
AMX0035
Amylyx
GeNeuro
NeuroSense Therapeutics
BrainStorm Cell Therapeutics
Flag link:
BrainStorm’s ALS Drug Heads to the FDA with Correction to Phase III Analyses
BrainStorm’s ALS Drug Heads to the FDA with Correction to Phase III Analyses
BioSpace
BrainStorm Cell Therapeutics
NurOwn
ALS
FDA
clinical trials
Flag link:
NurOwn: A Study in the Complexity of ALS Trials
NurOwn: A Study in the Complexity of ALS Trials
BioSpace
BrainStorm Cell Therapeutics
NurOwn
ALS
clinical trials
Flag link:
BrainStorm Trial Shows Promising Top-Line Results for Progressive Multiple Sclerosis
BrainStorm Trial Shows Promising Top-Line Results for Progressive Multiple Sclerosis
BioSpace
BrainStorm Cell Therapeutics
MS
clinical trials
multiple sclerosis
Flag link:
FDA calls out Brainstorm’s ALS stem cell therapy, says data don’t show benefit
FDA calls out Brainstorm’s ALS stem cell therapy, says data don’t show benefit
MedCity News
BrainStorm Cell Therapeutics
ALS
stem cell therapy
clinical trials
FDA
Flag link:
Despite red flag from FDA, controversial ALS cell therapy developer says it may still march ahead anyway
Despite red flag from FDA, controversial ALS cell therapy developer says it may still march ahead anyway
Endpoints
BrainStorm Cell Therapeutics
ALS
cell therapy
FDA
Flag link:
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
BrainStorm Cell Therapeutics
Allergan
Pfizer
Clovis Oncology
Acorda Therapeutics
Takeda
Agios Pharmaceuticals
Shire
Teva Pharmaceutical
AbbVie
Flag link:
ALS drug maker walks back plan to profit from right-to-try law following heavy criticism
ALS drug maker walks back plan to profit from right-to-try law following heavy criticism
Stat
BrainStorm Cell Therapeutics
right-to-try laws
ALS
clinical trials
NurOwn
Flag link:
Step right up: A biotech may soon sell an experimental med to dying ALS patients under ‘Right to Try’
Step right up: A biotech may soon sell an experimental med to dying ALS patients under ‘Right to Try’
Endpoints
right-to-try laws
ALS
BrainStorm Cell Therapeutics
Flag link:
Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
TheStreet.com
BrainStorm Cell Therapeutics
stem cells
clinical trials
ALS
NurOwn
Flag link:
Israel's BrainStorm says stem cell drug benefits most patients in ALS trial
Israel's BrainStorm says stem cell drug benefits most patients in ALS trial
Reuters
BrainStorm Cell Therapeutics
stem cells
ALS
Lou Gehrig's disease
NurOwn
Flag link:
Brainstorm Cell Therapeutics Hits One-Year High Today
Brainstorm Cell Therapeutics Hits One-Year High Today
TheStreet.com
BrainStorm Cell Therapeutics
stem cells
NurOwn
ALS
Lou Gehrig's disease
Flag link:
Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy
Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy
TheStreet.com
BrainStorm Cell Therapeutics
ALS
Flag link:
BrainStorm gets FDA fast-track status for ALS stem cell therapy
BrainStorm gets FDA fast-track status for ALS stem cell therapy
Yahoo/Reuters
BrainStorm Cell Therapeutics
FDA
ALS
stem cells
Flag link:
BrainStorm Receives Notice of Allowance on US Patent
BrainStorm Receives Notice of Allowance on US Patent
Yahoo
BrainStorm Cell Therapeutics
patents
stem cells
BDNF
brain-derived neurotrophic factor
Flag link:

Pages